Rezolve AI sits in an unusual configuration heading into its September 1 earnings report — the stock just posted its biggest single-session gain in months, yet short sellers are quietly adding exposure rather than running for cover.
The positioning story is the tension worth watching. Short interest has crept back up to 11.9% of the free float — roughly 35.9 million shares — after the week opened at 34.9 million. That's a week-on-week increase of nearly 6%, entirely counter to the 22% price move higher. The borrow market tells a consistent story: availability has tightened to 24.5%, down from 31% a week ago, meaning fewer than one share is available for every four already lent out. That's back near the early-August range that preceded the borrow crisis, when cost to borrow briefly hit 158% annualised. The rate has since collapsed — it's now running at 17.6% APR — but that's still expensive, and the tightening trend in availability this week signals fresh shorts are competing for a shrinking pool. Options traders, by contrast, look anything but panicked: the put/call ratio at 0.26 is below its 20-day average of 0.28, near the year's most call-heavy readings. The two signals diverge cleanly — the short book is growing, but the options desk is not rushing to hedge.
The fundamental picture offers bears genuine ammunition. Valuation multiples are deeply negative — the EV/EBITDA ratio is running at roughly -870x, a reflection of meaningful operating losses rather than a quirky accounting artifact — and the ORTEX short score, while easing slightly from its August peak of 79.9, still registers at 76.0. That places the stock in the bottom decile of the broader universe on short-score rank. Growth is the one structural bull case: ORTEX factor scores give the company an exceptional growth pillar, underpinned by analyst expectations for revenues to roughly double in 2026. But quality and value scores remain deeply unflattering, and the FINRA-reported days-to-cover of 3.77 means any forced covering event would take time to clear through the market.
Ownership is concentrated and lightly institutionalised. The top holders are largely insiders and early backers — founder Daniel Wagner holds around 1.2% directly, with Alejandro Gonzalez notably adding 7.25 million shares in the most recent filing period. The most recent insider purchases on record date to May 2026 — a director buy near $2.78 — so insider activity, while net positive over the prior 90-day window, is now stale by more than three months. The genuine institutional footprint is thin: UBS Asset Management, Hudson River Trading, Jane Street, and Susquehanna all appear in the June filings, but each holds under 1% of the company.
Earnings reactions have been modest in both directions. The three prior reported quarters produced next-day moves of +5.0%, +3.2%, and -0.8% respectively. The five-day window has been choppier — ranging from -2.2% to +9.9% — suggesting the bigger moves tend to develop after the initial reaction fades. Peers HOLO and CRNC both posted material moves this week (HOLO up 18%, CRNC down 5%), illustrating how much dispersion exists in this corner of the AI software space right now. PLTR, the highest-profile name in the correlated peer group, was roughly flat on the week — a reminder that the volatility here is largely RZLV-specific rather than sector-wide.
What to watch next is whether short interest continues to build into the September 1 print — or whether borrow availability tightens further and forces a reversal before the report even lands.
See the live data behind this article on ORTEX.
Open RZLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
